In the past week, BIVI stock has gone up by 34.09%, with a monthly gain of 29.94% and a quarterly plunge of -28.75%. The volatility ratio for the week is 18.91%, and the volatility levels for the last 30 days are 15.86% for BioVie Inc The simple moving average for the past 20 days is 33.82% for BIVI’s stock, with a -46.16% simple moving average for the past 200 days.
Is It Worth Investing in BioVie Inc (NASDAQ: BIVI) Right Now?
The 36-month beta value for BIVI is also noteworthy at 1.17. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for BIVI is 16.04M, and at present, short sellers hold a 7.09% of that float. The average trading volume of BIVI on May 06, 2025 was 440.59K shares.
BIVI) stock’s latest price update
BioVie Inc (NASDAQ: BIVI) has experienced a decline in its stock price by -5.79 compared to its previous closing price of 1.21. However, the company has seen a gain of 34.09% in its stock price over the last five trading days. globenewswire.com reported 2025-04-30 that NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against BioVie Inc. (NASDAQ: BIVI) on behalf of long-term stockholders following a class action complaint that was filed against BioVie on January 19, 2024 with a Class Period from August 5, 2021 to November 29, 2023. Our investigation concerns whether the board of directors of BioVie have breached their fiduciary duties to the company.
Analysts’ Opinion of BIVI
Many brokerage firms have already submitted their reports for BIVI stocks, with Cantor Fitzgerald repeating the rating for BIVI by listing it as a “Overweight.” The predicted price for BIVI in the upcoming period, according to Cantor Fitzgerald is $7 based on the research report published on July 22, 2022 of the previous year 2022.
B. Riley Securities, on the other hand, stated in their research note that they expect to see BIVI reach a price target of $47. The rating they have provided for BIVI stocks is “Buy” according to the report published on January 15th, 2021.
BIVI Trading at 12.82% from the 50-Day Moving Average
After a stumble in the market that brought BIVI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -84.80% of loss for the given period.
Volatility was left at 15.86%, however, over the last 30 days, the volatility rate increased by 18.91%, as shares surge +47.10% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -22.97% lower at present.
During the last 5 trading sessions, BIVI rose by +34.09%, which changed the moving average for the period of 200-days by -74.55% in comparison to the 20-day moving average, which settled at $0.8519. In addition, BioVie Inc saw -43.00% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for BIVI
The total capital return value is set at -0.99. Equity return is now at value -154.54, with -102.89 for asset returns.
Based on BioVie Inc (BIVI), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -57.65. The debt to equity ratio resting at 0.02. The interest coverage ratio of the stock is -17.21.
Currently, EBITDA for the company is -31.95 million with net debt to EBITDA at 1.05. The liquidity ratio also appears to be rather interesting for investors as it stands at 16.94.
Conclusion
In summary, BioVie Inc (BIVI) has had a mixed performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
